DNA NYSE
Ginkgo Bioworks Holdings, Inc.
1W: +2.8%
1M: -4.4%
3M: -12.5%
YTD: -7.2%
1Y: +1.0%
3Y: -83.9%
5Y: -98.0%
$8.41
+0.33 (+4.08%)
Weekly Expected Move ±14.7%
$5
$7
$8
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$549.4M
52W Range5.37-17.58
Volume879,660
Avg Volume1,255,206
Beta1.78
Dividend—
Analyst Ratings
Company Info
CEOJason Kelly
Employees834
SectorHealthcare
IndustryBiotechnology
IPO Date2021-04-19
Websiteginkgobioworks.com
27 Drydock Avenue
Boston, MA 02210
US
Boston, MA 02210
US
877 422 5362
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Latest News
Ginkgo Bioworks (DNA) Q1 2026 Earnings Transcript
Ginkgo Bioworks slumps 14% after projecting FY26 cash burn of $125M-$150M
Ginkgo outlines $125M-$150M 2026 cash burn guidance while expanding Nebula to 103 racks
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Coen Steven P. | S-Sale | 324 | $7.95 | 2026-04-17 |
| Coen Steven P. | M-Exempt | 156 | — | 2026-04-16 |
| Coen Steven P. | M-Exempt | 587 | — | 2026-04-16 |
| Coen Steven P. | M-Exempt | 587 | — | 2026-04-16 |
| Coen Steven P. | M-Exempt | 156 | — | 2026-04-16 |